Estimaciones de analistas de Wall Street para NRC Health (NRC): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-10-26 | $0.21 | ||
| 2026-07-28 | $0.31 | $-0.15 | +306.7% |
| 2026-04-28 | $0.21 | ||
| 2026-02-03 | $0.16 | ||
| 2025-10-27 | $0.23 | ||
| 2025-07-28 | $0.28 | ||
| 2025-04-28 | $0.25 | ||
| 2025-02-11 | $0.36 |
Ratios de valoración
| Ratio P/E | 84.00 |
| Precio / Valor contable | 74.10 |
| EV / EBITDA | 24.03 |
| Rentabilidad por dividendo | 2.72% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $109.4M | $117.6M | $119.7M | $128.0M | $133.3M | $148.0M | $151.6M | $148.6M | $143.1M | $137.4M |
| Coste de Ventas | $45.6M | $49.1M | $47.6M | $46.4M | $49.2M | $52.4M | $57.0M | $56.0M | $56.9M | $60.0M |
| Beneficio Bruto | $63.8M | $68.5M | $72.1M | $81.5M | $84.1M | $95.6M | $94.5M | $92.6M | $86.1M | $77.4M |
| I+D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $28.4M | $29.7M | $31.4M | $33.0M | $34.4M | $39.0M | $42.7M | $46.6M | $44.9M | $54.8M |
| Gastos Operativos | $32.6M | $34.3M | $36.8M | $38.5M | $41.4M | $45.3M | $48.0M | $52.5M | $50.9M | $54.8M |
| Beneficio Operativo | $31.2M | $34.2M | $35.3M | $43.0M | $42.7M | $50.3M | $46.5M | $40.0M | $35.2M | $22.6M |
| EBITDA | $35.8M | $39.0M | $41.7M | $48.6M | $50.8M | $56.7M | $49.3M | $46.0M | $41.3M | $30.2M |
| Gastos por Intereses | $190000 | $82000 | $1.5M | $2.1M | $1.8M | $1.7M | $1.2M | $862000 | $2.6M | $4.8M |
| Beneficio Antes de Impuestos | $31.4M | $34.3M | $34.7M | $40.5M | $41.5M | $48.6M | $42.8M | $40.0M | $32.7M | $17.8M |
| Impuestos | $10.8M | $11.3M | $4.7M | $8.1M | $4.2M | $11.2M | $11.0M | $9.0M | $7.9M | $6.2M |
| Beneficio Neto | $20.5M | $22.9M | $30.0M | $32.4M | $37.3M | $37.5M | $31.8M | $31.0M | $24.8M | $11.6M |
| BPA | $0.49 | $0.54 | $1.11 | $1.30 | $1.48 | $1.47 | $1.28 | $1.26 | $1.05 | $0.52 |
| BPA Diluido | $0.48 | $0.52 | $1.07 | $1.26 | $1.45 | $1.46 | $1.27 | $1.25 | $1.04 | $0.52 |
| Acciones en Circulación (Diluidas) | $24.6M | $25.2M | $28.1M | $25.7M | $25.7M | $25.6M | $25.1M | $24.7M | $23.7M | $22.4M |
Precio
| Precio | $22.05 |
| Capitalización | $497M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: DH · HCAT · NNOX · PBYI · QTRX · SNWV · SOPH
Explorar sector: Healthcare · Medical - Healthcare Information Services
Más secciones de NRC: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones